MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Carcinogenesis

• Publication date

  2011-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/carcin/bgr223PMID 21983127PMCID PMC3220613
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pancreatic cancer.

  2013cited by this paper
• MUC4: A novel prognostic factor of oral squamous cell carcinoma

  2012cited by this paper
• MicroRNA expression profiles in human colorectal cancers with liver metastases.

  2011cited by this paper
• MicroRNAs 103 and 107 regulate insulin sensitivity

  2011cited by this paper
• The role of microRNA-150 as a tumor suppressor in malignant lymphoma

  2011cited by this paper
• miR 488* inhibits androgen receptor expression in prostate carcinoma cells

  2011cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• MicroRNA-based Cancer Therapeutics: Big Hope from Small RNAs.

  2010cited by this paper
• Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

  2010cited by this paper
• CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy

  2010cited by this paper
• MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.

  2010cited by this paper
• Abstract 2350: MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1

  2010cited by this paper
• MicroRNAs in Cancer.

  2009cited by this paper
• Muc4/MUC4 functions and regulation in cancer.

  2009cited by this paper
• MicroRNAs in cancer: small molecules with a huge impact.

  2009cited by this paper
• miRNA analysis in B‐cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR‐150 and high BIC/miR‐155 expression

  2008cited by this paper
• Structure, evolution, and biology of the MUC4 mucin

  2008cited by this paper
• MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells.

  2008cited by this paper
• MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells

  2008cited by this paper
• Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals.

  2008cited by this paper
• Pancreatic Carcinogenesis

  2008cited by this paper
• MicroRNAs miR-186 and miR-150 Down-regulate Expression of the Pro-apoptotic Purinergic P2X7 Receptor by Activation of Instability Sites at the 3′-Untranslated Region of the Gene That Decrease Steady-state Levels of the Transcript*

  2008cited by this paper
• MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb.

  2007cited by this paper
• Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.

  2007cited by this paper
• MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms

  2007cited by this paper
• MUC4 Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins

  2007cited by this paper
• MUC 4 Mucin Potentiates Pancreatic Tumor Cell Proliferation , Survival , and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins

  2007cited by this paper
• MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma

  2007cited by this paper
• MUC Genes Are Differently Expressed During Onset and Maintenance of Inflammation in Dextran Sodium Sulfate-Treated Mice

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• Expression profiling identifies microRNA signature in pancreatic cancer

  2006cited by this paper
• Real-time quantification of microRNAs by stem–loop RT–PCR

  2005cited by this paper
• MicroRNAs as oncogenes and tumor suppressors.

  2005cited by this paper
• Recent Advances on the Molecular Mechanisms Involved in Pancreatic Cancer Progression and Therapies

  2005cited by this paper
• Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis

  2004cited by this paper
• Pancreatic cancer

  2004cited by this paper
• Mucins in cancer: protection and control of the cell surface

  2004cited by this paper
• MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.

  2002cited by this paper
• Pancreatic cancer biology and genetics

  2002cited by this paper
• Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive.

  2002cited by this paper
• Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.

  2001cited by this paper
• Cancer statistics

  1989cited by this paper

• miR-150 in cancer metastasis: Orchestrating migration, invasion, and angiogenesis through context-dependent mechanisms.

  2025cites this paper
• ITGB7 Remodels Inflammation and Immune Microenvironment and Enhances Checkpoint Inhibitor-Based Immunotherapy in Pancreatic Cancer

  2025cites this paper
• miR‐150‐5p Regulates Merkel Cell Carcinoma Progression by Targeting FTO That Stabilizes CTNNB1 via m6A Modification

  2025cites this paper
• MicroRNA-335 inhibits invasion and metastasis of prostate cancer by inhibiting glutamine metabolism pathway.

  2024cites this paper
• Using microRNAs Networks to Understand Pancreatic Cancer—A Literature Review

  2024cites this paper
• Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer

  2024influential citation
• Cortisol affects macrophage polarization by inducing miR-143/145 cluster to reprogram glucose metabolism and by promoting TCA cycle anaplerosis

  2024cites this paper
• iPSC-Derived Pancreatic Progenitors Lacking FOXA2 Reveal Alterations in miRNA Expression Targeting Key Pancreatic Genes

  2023cites this paper
• Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer

  2023cites this paper
• Advances in MUC1 resistance to chemotherapy in pancreatic cancer

  2023cites this paper
• Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms

  2023cites this paper
• Microbiome and MicroRNA or Long Non-Coding RNA—Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma

  2023cites this paper
• Pathological implications of mucin signaling in metastasis.

  2023cites this paper
• Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer

  2022cites this paper
• Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy

  2022cites this paper
• Pancreatic cancer and oligonucleotide therapy: exploring novel therapeutic options and targeting chemoresistance.

  2022cites this paper
• MicroRNA: Crucial modulator in purinergic signalling involved diseases

  2022cites this paper
• Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics

  2022cites this paper
• MicroRNA: Crucial modulator in purinergic signalling involved diseases

  2022cites this paper
• Palbociclib suppresses the cancer stem cell properties and cell proliferation through increased levels of miR-506 or miR-150 in Panc-1 and MiaPaCa-2 cells

  2022influential citation
• A novel therapeutic strategy for alleviating atrial remodeling by targeting exosomal miRNAs in atrial fibrillation.

  2022cites this paper
• Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities.

  2022cites this paper
• Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives.

  2022cites this paper
• How metformin affects various malignancies by means of microRNAs: a brief review

  2021cites this paper
• The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma

  2021cites this paper
• Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma

  2021cites this paper
• MicroRNA-204 attenuates oxidative stress damage of renal tubular epithelial cells in calcium oxalate kidney-stone formation via MUC4-mediated ERK signaling pathway

  2021cites this paper
• LINC00857 promotes colorectal cancer progression by sponging miR-150-5p and upregulating HMGB3 (high mobility group box 3) expression

  2021cites this paper
• The role of membrane mucin MUC4 in breast cancer metastasis.

  2021cites this paper
• Role of human nucleoside transporters in pancreatic cancer and chemoresistance

  2021cites this paper
• The Role of microRNA in Pancreatic Cancer

  2021cites this paper
• The increased miRNA-150-5p expression of the tonsil tissue in patients with IgA nephropathy may be related to the pathogenesis of disease.

  2021cites this paper
• Resistin Induces LIN28A-Mediated Let-7a Repression in Breast Cancer Cells Leading to IL-6 and STAT3 Upregulation

  2021cites this paper
• MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer

  2021cites this paper
• Ras and Ras Signaling as a Therapeutic Target in Cancer

  2021cites this paper
• MicroRNA-Regulated Signaling Pathways: Potential Biomarkers for Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• Mucin expression, epigenetic regulation and patient survival: A toolkit of prognostic biomarkers in epithelial cancers.

  2021cites this paper
• Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy

  2021cites this paper
• Integrated analysis of miRNA‐mRNA networks reveals a strong anti‐skin cancer signature in vitiligo epidermis

  2021cites this paper
• MicroRNA-150 suppresses p27Kip1 expression and promotes cell proliferation in HeLa human cervical cancer cells

  2020cites this paper
• Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs

  2020cites this paper
• Noncoding RNAs: the shot callers in tumor immune escape

  2020cites this paper
• LINC00152 promotes pancreatic cancer cell proliferation, migration and invasion via targeting miR-150.

  2020cites this paper
• TRPM Channels in Human Diseases

  2020cites this paper
• The association between circulating MicroRNA‐150 level and cholangiocarcinoma

  2020cites this paper
• lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA‐150

  2019cites this paper
• TRPM4 channel and cancer.

  2019cites this paper
• Dysregulation of key microRNAs in pancreatic cancer development.

  2019cites this paper
• MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway.

  2019cites this paper
• Supervised Discriminative Sparse PCA for Com-Characteristic Gene Selection and Tumor Classification on Multiview Biological Data

  2019cites this paper
• MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential

  2019influential citation
• Exome sequencing identifies predisposing and fusion gene in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.

  2019cites this paper
• circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer

  2019cites this paper
• Depletion of the lncRNA RP11-567G11.1 inhibits pancreatic cancer progression.

  2019cites this paper
• Role of microRNA-150-5p/SRCIN1 axis in the progression of breast cancer

  2019cites this paper
• Pancreatic cancer resistance to chemotherapy

  2019cites this paper
• Dextran-coated iron oxide nanoparticle for delivery of miR-29a to breast cancer cell line

  2019cites this paper
• XIST accelerates neuropathic pain progression through regulation of miR‐150 and ZEB1 in CCI rat models

  2018cites this paper
• The role of contact guidance on cancer metastasis

  2018cites this paper
• HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development

  2018cites this paper
• Retrospective screening of microarray data to identify candidate IFN-inducible genes in a HTLV-1 transformed model

  2018cites this paper
• MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4

  2018cites this paper
• Long Non-Coding RNA PVT1/miR-150/ HIG2 Axis Regulates the Proliferation, Invasion and the Balance of Iron Metabolism of Hepatocellular Carcinoma

  2018cites this paper
• Pancreatic Cancer Gene Therapy Delivered by Nanoparticles

  2018cites this paper
• Clinical significance of miRNA-21, -103, -129, -150 in serous ovarian cancer

  2018cites this paper
• Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets.

  2018cites this paper
• MicroRNA-150 inhibits the proliferation and metastasis potential of colorectal cancer cells by targeting iASPP

  2018cites this paper
• MicroRNA‐150 restores endothelial cell function and attenuates vascular remodeling by targeting PTX3 through the NF‐κB signaling pathway in mice with acute coronary syndrome

  2018cites this paper
• MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma

  2017cites this paper
• Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward

  2017influential citation
• Role of phytochemicals in the modulation of miRNA expression in cancer.

  2017cites this paper
• Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.

  2017cites this paper
• Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach

  2017cites this paper
• MicroRNA-150 functions as an antioncogenic regulator in osteosarcoma.

  2017cites this paper
• Dysregulated expression of microRNA‐150 in human papillomavirus‐induced lesions of K14‐HPV16 transgenic mice

  2017cites this paper
• MicroRNA-150 as a Potential Biomarker in Diagnosis of Cancer: a Meta-Analysis.

  2017cites this paper
• miR-150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma

  2017cites this paper
• MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4.

  2017cites this paper
• Dual strands of pre-miR‑150 (miR‑150‑5p and miR‑150‑3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer.

  2017cites this paper
• MicroRNA-202-3p inhibits cell proliferation and induces cell apoptosis by targeting MUC4 in human NSCLC

  2017cites this paper
• MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.

  2017cites this paper
• HPCDb: an integrated database of pancreatic cancer

  2017cites this paper
• Liquid Biopsy in Cancer Patients

  2017cites this paper
• MicroRNA-150 targets Rho-associated protein kinase 1 to inhibit cell proliferation, migration and invasion in papillary thyroid carcinoma.

  2017cites this paper
• Liquid Biopsies in Malignant Melanoma: From Bench to Bedside

  2017cites this paper
• Mécanismes de régulation post-transcriptionnelle de l'expression des mucines par la galectine-3

  2017cites this paper
• MiR-150 inhibits hypoxia-induced autophagy in oral squamous carcinoma by negatively regulating BNIP 3

  2017cites this paper
• MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4

  2016cites this paper
• MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer

  2016cites this paper
• MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis

  2016cites this paper
• The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms

  2016cites this paper
• Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application

  2016cites this paper
• Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism

  2016cites this paper
• Mucins and Wnt/β-catenin signaling in gastrointestinal cancers: an unholy nexus.

  2016cites this paper
• Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and prevention

  2016cites this paper
• Identification of plasma microRNA expression profile in radiographic axial spondyloarthritis—a pilot study

  2016cites this paper
• OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted Therapy.

  2016cites this paper
• MicroRNA in pancreatic cancer

  2016cites this paper
• The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin.

  2016cites this paper
• The canonical Wnt pathway regulates the metastasis‐promoting mucin MUC4 in pancreatic ductal adenocarcinoma

  2016cites this paper